PMC3589117_01
Ocular fundus findings at the initial examination of the patient showed (A) Right eye: PDR with fibrovascular membrane, preretinal hemorrhage, and tractional retinal detachment; and (B) Left eye: PDR with fibrovascular membrane.. Abbreviation: PDR, proliferative diabetic retinopathy.
opth-7-449f1.jpg
PMC3589117_01_opth-7-449f1.jpg
f1-opth-7-449
Fundus examination of the patient revealed PDR with fibrovascular membrane, preretinal hemorrhage, and tractional retinal detachment in his right eye; and PDR with fibrovascular membrane in his left eye (Figure 1).
Slit-lamp biomicroscopy and gonioscopy findings at the visit on October 16, 2010.. Note: The left eye showed iris neovascularization, PAS index: 60%.. Abbreviation: PAS, peripheral anterior synechia.
opth-7-449f2.jpg
PMC3589117_01_opth-7-449f2.jpg
f2-opth-7-449
IOP was 12 mmHg in his left eye. In addition, iris neovascularization, ectropion uvea, and tractional retinal detachment were found, and peripheral anterior synechia (PAS) index was approximately 60% in his left eye (Figure 2).
Transfer of a pars plana AGV  tube into the anterior chamber. (A) The tube being inserted into the vitreous body; (B) The tube being pulled out from the vitreous cavity; and (C) The tube being inserted into the anterior chamber.. Abbreviation: AGV , Ahmed  glaucoma valve.
opth-7-449f3.jpg
PMC3589117_01_opth-7-449f3.jpg
f3-opth-7-449
During that operation, the tube was pulled out from the vitreous cavity and inserted into the anterior chamber, in order to avoid complications caused by the silicone oil (Figure 3, Supplementary material).
Slit-lamp biomicroscopy and ocular fundus findings after the patient's final surgery. (A) A pars plana AGV  tube inserted into the anterior chamber; and (B) PDR was stable, with no recurrence of vitreous hemorrhage.. Abbreviations: AGV , Ahmed  glaucoma valve; PDR, proliferative diabetic retinopathy.
opth-7-449f4.jpg
PMC3589117_01_opth-7-449f4.jpg
f4-opth-7-449
He suffered no recurrence of vitreous hemorrhage and no complications, such as disorder of eye movement (Figure 4).